APA (7th ed.) Citation

MD, H., GD, R., & SP, S. (2023). Real-World Application of Anti-β-Amyloid Monoclonal Antibodies: Untangling Eligibility. Neurology, 101(19), 811. https://doi.org/10.1212/WNL.0000000000207873

Chicago Style (17th ed.) Citation

MD, Howe, Rabinovici GD, and Salloway SP. "Real-World Application of Anti-β-Amyloid Monoclonal Antibodies: Untangling Eligibility." Neurology 101, no. 19 (2023): 811. https://doi.org/10.1212/WNL.0000000000207873.

MLA (9th ed.) Citation

MD, Howe, et al. "Real-World Application of Anti-β-Amyloid Monoclonal Antibodies: Untangling Eligibility." Neurology, vol. 101, no. 19, 2023, p. 811, https://doi.org/10.1212/WNL.0000000000207873.